68 related articles for article (PubMed ID: 3302851)
1. [Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination].
Drugeon HB; Dellamonica P; Caillon J
Pathol Biol (Paris); 1987 May; 35(5):495-500. PubMed ID: 3302851
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
[TBL] [Abstract][Full Text] [Related]
3. [In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
Quentin C; Noury P; Laurent C; Saivin S; Bebear C
Pathol Biol (Paris); 1987 Feb; 35(2):153-7. PubMed ID: 3550623
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
[TBL] [Abstract][Full Text] [Related]
5. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Ishag AJ; Durgham SM; Shibl AM
Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
[TBL] [Abstract][Full Text] [Related]
7. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Drugeon HB; Caillon J; Juvin ME
J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
[TBL] [Abstract][Full Text] [Related]
8. [Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis].
Zuccarelli M; Simeon de Buochberg M; Maillols H; Dusart G; Attisso MA
Pathol Biol (Paris); 1988 May; 36(5):410-3. PubMed ID: 3136423
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
Debbia E; Schito GC; Nicoletti G; Speciale A
Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
[TBL] [Abstract][Full Text] [Related]
11. [The combined effect of methicillin and teicoplanin against Staphylococcus aureus strains investigated in vitro].
Młynarczyk A; Młynarczyk G; Luczak M
Med Dosw Mikrobiol; 2005; 57(1):1-6. PubMed ID: 16130290
[TBL] [Abstract][Full Text] [Related]
12. Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin.
Tsuji BT; Rybak MJ
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):73-7. PubMed ID: 16368477
[TBL] [Abstract][Full Text] [Related]
13. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
14. Effects of subinhibitory concentrations of pefloxacin on the adherence of Staphylococcus aureus to human cells.
Desnottes JF; Diallo N; Moret G; Santonja R
Drugs Exp Clin Res; 1987; 13(2):69-73. PubMed ID: 3472868
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
[TBL] [Abstract][Full Text] [Related]
16. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
Hamel A; Caillon J; Jacqueline C; Batard E; Potel G
Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
[TBL] [Abstract][Full Text] [Related]
18. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
Aepfelbacher M
MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
[TBL] [Abstract][Full Text] [Related]
19. [Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria (author's transl)].
Zemelman R; González C; Mondaca MA
Rev Med Chil; 1980 Dec; 108(12):1112-7. PubMed ID: 7302408
[No Abstract] [Full Text] [Related]
20. Bactericidal effect of ofloxacin alone and combined with fosfomycin or vancomycin against Staphylococcus aureus in vitro and in sera from volunteers.
Weber P; Boussougant Y; Ichou F; Dutoit C; Carbon C
J Antimicrob Chemother; 1987 Dec; 20(6):839-47. PubMed ID: 3481627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]